Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-22-018749

10% owner bought 2,850,000 shares at $10.00 ($28,500,000)

  • 10% owner acquired 2,785,000 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Chen Bihua 10% owner 2022-04-05 Conversion +2,785,000 3,215,000 I
Chen Bihua 10% owner 2022-04-05 Purchase +2,850,000 $10.00 $28,500,000 2,850,000 I
Derivatives
Chen Bihua 10% owner 2022-04-05 Conversion · Class B Ordinary Shares −2,785,000 0 I
Open-market purchases · 2,850,000 sh · avg $10.00 · $28,500,000
Loading xslF345X03/ownership.xml…